Skip to content

Long term vascular and psychosocial complications in adolescent and young adult survivors of head and neck cancer treated with radiotherapy.

Long term vascular and psychosocial complications in adolescent and young adult survivors of head and neck cancer treated with radiotherapy. - Late Effects Head and Neck Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48049
Enrollment
40
Registered
2019-11-25
Start date
2020-01-22
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular toxicity

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients treated with unilateral radiotherapy of the neck at adolescent or young adult age (18-40 year) 5-10 years before. - Competent to make own discicions - *18 years of age

Exclusion criteria

Exclusion criteria: - Contra indication MRI - Not able to understand the Dutch language

Design outcomes

Primary

MeasureTime frame
1. Vascular complications: a. Intima Media thickness on ultrasonography in the irradiated versus the non-irradiated artery b. Carotid wall elastography on ultrasonography in the irradiated versus the non-irradiated artery c. Carotid wall thickness on MRI in the irradiated versus the non-irradiated artery d. Radiological characteristics of carotid wall changes on MRI of the irradiated versus the non-irradiated artery e. Cerebral infarctions and white matter lesions on MRI f. Cardiovascular risk profile 5-10 years after radiotherapy because of HNC

Secondary

MeasureTime frame
2. Psychosocial complications: a. Cognitive function 5-10 years after RT in HNC patients b. Frequency of memory complaints, anxciety, depression, fatique c. Employment ability

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)